Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease

Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD)

Bron
Frontiers in molecular medicine - ISSN 2674-0095-3 (2024) p. 1-19
Auteur(s)

Ferroptosis and pyroptosis signatures in critical COVID-19 patients

Bron
Cell death and differentiation - ISSN 1350-9047-30:9 (2023) p. 2066-2077
Auteur(s)